Genomics and Molecular Biology-2018 a leading International forum to disseminate all the branches of Genetics, Bioinformatics and Computational Biology, Structural and Functional Genomics, and Molecular Biology. Provides a critical review of present state of subject. This conference is being organized to provide a foremost interdisciplinary global platform to all the Eminent Researcher’s, Practitioners, Molecular biologists, Educators, Scientists, Delegates, Speakers from Institutions, Industries, Private and Government Laboratories across the globe to discuss the contemporary innovations and upcoming challenges in their respective fields. This conference has a platform to fill all the prevailing gaps in the Genetics and Molecular Biology. You are all welcome to Madrid, Spain by your valuable presence during 26th and 27th of November, 2018.
Genomics is the study of Genomes, Genetic variation and Heredity in living organisms. Generally Genomics is a branch of biology, but it frequently intersects with many life sciences.
Molecular Biology deals with the study of molecular processes of replication, transcription, translation and cell function where genetic material is transcribed into RNA and then gets translated into proteins. Majority of molecular biology is quantitative, and in recent times much of the work has been done at interface of Molecular Biology and computer sciences in Bioinformatics and Computer biology.
Genomics and Molecular Biology will attract large group of scientists and researchers all around the globe. We are delight to invite Researchers,Practitioners, Educators, Nobel laureates, Renowned speakers, Young researchers, Students and Delegates from Associations, Societies, to a new initiative, Genomics and Molecular Biology-2018 going to be conducted in Madrid, Spain on 26th and 27th of November, 2018.
Allied Academies is an International Collaborative venture incorporating Academicians, Researchers, Scholars and business entrepreneurs to exchange information from past two decades through international scientific meetings and Journals. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies. The conferences provide a global platform for the attendees to showcase their research and services in front of many key players in the field.
We are a globally recognized and trusted organization to provide Unique scientific and business services through our Journals and we are expanding the functionality of our International conferences.
Sessions and Track
1: Genomic Study
Genomics deals with the study of full genetic complement of an organism (the genome).It employs recombinant DNA sequencing methods, bioinformatics,assemble and analyses the structure and function of genomes.
Genomics involves the study of molecular biology, intragenomic processes such as epistasis, heterosis and pleiotropy as well as the interactions between loci and alleles within the genome. The fields of molecular biology and genetics are mainly concerned with the study of the role and function of single genes, which is a supreme topic in today’s biomedical research.
Session 2: Cancer Immunogenomics
The application of modern high throughput genomics to the study of cancer genomes has exploded in the past few years, yielding unanticipated insights into the myriad and tangled combinations of genomic alterations that lead to the development of cancers.
Session 3: Human Genomics and Genetic Disorders
Human genetics is the study of inheritance as it occurs in human beings. A human genetics quality envelops an assortment of covering fields including classical genetics, crypto genetics, molecular genetics, biochemical genetics, genomics, population genetics, developmental genetics, clinical genetics, and genetic counseling.
Session 4: Molecular and Cellular Biology
Molecular and cellular biology showcases fundamental discoveries in gene expression and genome organization, cellular morphology and function, molecular metabolism, cellular trafficking, and signal transduction. Sub atomic science concerns the sub atomic premise of natural action between the different frameworks of a cell, including the collaborations between the diverse kinds of DNA, RNA and proteins and their biosynthesis, and concentrates how these associations are managed. It has numerous applications like in quality finding, sub atomic systems of sickness and its remedial methodologies by cloning, articulation and direction of quality.
Session 5: Plant Genomics and Plant Sciences
Major efforts are directed to explore genomic tools, such as sequencing, transcriptomics, proteomics, and molecular markers, to identify regulators, genes and strategies responsible for resistance to pests and diseases and for tolerance to water deficit, salinity and temperature stress. The study of bioactive compounds and potential health beneficial effects of food metabolites also performed.
Session 6: Animal Genomics
Animal genetics and genomics is the branch of science concerned with maximizing desirable genetic traits, such as producing animals that have leaner meat. Hybrid Analysis is the key strategy to study the inheritance of characters and it decides the idea of numerous morphological, physiological and biochemical characteristics which much of the time depend just on one of a few sets of genes. Animal geneticists have identified elements within genes that can enhance animal growth, health, and ability to utilize nutrients. These genetic advances can increase production while reducing environmental impacts.
Advances in Animal breeding, Genetics, and Genomics are facilitating a more efficient industry. For example, the number of cattle has decreased over the past decade, yet the total production of beef and milk has increased. This was largely possible because genetic advancements led better animal feed efficiency, which is critical to improving livestock production and lowering costs for producers.
Session 7: Clinical Genomics
Clinical genomics is the use of genome sequencing to inform patient’s diagnosis and care. It is a unused and fluctuating field. Knowledge of human genome is far from complete, but there are already uses for genetic and genomic information in the clinic.
Session 8: Pharmacogenomics
Pharmacogenomics focuses on the identification of genome variants that influence drug effects, typically alterations in a drug’s pharmacokinetics (absorption, distribution, metabolism, elimination) or modulation of a drug’s pharmacodynamics ( modifying a drug’s target or perturbing biological pathways that alter sensitivity to the drug’s pharmacological effects).It deals with drug effects differences caused by variation in genetics. Pharmacogenomics has an immense role to ensure maximum efficacy and to minimize adverse effects and in maintenance of quality of life
Session 9: Whole Genome Association Study
Whole genome association study or genome wide association study is an approach that involves rapidly scanning markers across the complete sets of DNA, or genomes, of many people to find genetic variations associated with a particular disease. Based on this, if any genetic associations are identified, researchers can use the information to develop better strategies to detect, treat and prevent the disease. Such studies are particularly useful in finding genetic variations that contribute to common, complex diseases, such as asthma, cancer, diabetes, heart disease and mental illnesses.
Session 10: Transcriptomics
Transcriptomics deals with study of transcriptome, the complete set of RNA transcripts that are produced by the genome. Transcriptome is a collection of all RNA present in a cell or a population of cells across any biological conditions. The transcriptome is dynamic, as the levels of RNA transcripts vary during different developmental stages or in response to certain conditions.
Session 11: Comparative Genomics
Comparative genomics involves evolutionary biology phenotypic reconstruction and deals with analysis and alignment of genes and genomes of living and extinct organisms from common ancestor. The application of genetic studies to both humans and model systems allows for a new paradigm, whereby a novel comparative genomics strategy collaborated with phenotypic correlates can be used to bridge between clinical relevance and model utility.
Session 12: Bacterial Genomics
The pace of technical advancement in microbial genomics has been breathtaking. Microbial genomes are widely variable and reflect the enormous diversity of bacteria, Achaea and lower eukaryotes. The study of microbial genomes helps us to better understand the broader biology of bacteria, and how their genetic composition.
Session 13: Genetic Mapping
Genetic mapping deals with location and identification of genes or group of genes that determines particular inherited trait.
Genetic maps have been using successfully to find the gene responsible for relatively rare, single-gene inherited disorders such as cystic fibrosis and Duchene muscular dystrophy. Genetic maps are also useful in guiding scientists to the many genes that are responsible in the development of more common disorders such as asthma, heart disease, diabetes, cancer, and psychiatric conditions.
Session 14: Gene Cloning
Gene cloning is a genetic engineering technique that promotes the production of genetically identical copies of a DNA sequence. The DNA with a target gene is split into fragments using restriction enzymes and then inserted into cloning vectors like plasmids which transfer the recombinant DNA to suitable host cells, such as the bacterium E. coli.
Session 15: Biomarkers
Clinically used biomarkers are required for regulatory and therapeutic decision making regarding drugs and their indication in order to bring new medicines to appropriate persons faster than they are today. Biomarkers are proposed to measure delivery of drugs at intended site, understand and predict pathophysiology.
Session 16: Genetic Mutations
Mutations are changes in the genetic sequence, which is the main cause of diversity among organisms. These changes occur at many different levels, and they can have widely differing consequences. In biological systems that are capable of reproduction, focusing on whether they are heritable, specifically, some mutations affect only the individual that carries them, while others affect all of the carrier organism's offspring, and further descendants.
Session 17: Gene Editing
Genome editing (gene editing) is a group of technologies that give the ability to change an organism's DNA. These technologies allow genetic material to be added, removed, or altered at particular locations in the genome. Several approaches to genome editing have been developed. A recent one is known as CRISPR-Cas9, which is short for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9.
Session 18: Gene Sequencing
Technological improvements and automation have increased speed and lowered costs to the point where individual genes can be sequenced routinely, and some labs can sequence well over 100,000 billion bases per year, and an entire genome can be sequenced for just a few thousand dollars.
Many of these new technologies were developed with support from the National Human Genome Research Institute (NHGRI) Genome Technology Program and its Advanced DNA Sequencing Technology awards. One of NHGRI's goals is to promote new technologies that could eventually reduce the cost of sequencing a human genome of even higher quality than is possible today and for less than $1,000.
Session 19: Stem Cell Biology
An undifferentiated cell that can divide to produce some offspring cells that continues as stem cells and some cells that are destined to differentiate. Stem cells are an ongoing source of the differentiated cells that make up the tissues and organs of animals and plants. There is a great interest in stem cells because of having potential in the development of therapies for replacing defective or damaged cells resulting from a variety of disorders and injuries, such as Parkinson disease, heart disease, and diabetes.
Session 20: Bioinformatics and Computational Biology
Bioinformatics and computational biology is an collaborative field that develops and applies computational methods in analyzing huge collection of biological data such as genetic sequencing, cell population.
Bioinformatics addresses specific needs in data acquisition, storage, analysis and integration that research in genomics generates. Bioinformatics nowadays has an essential role both, in deciphering genomic, transcriptomic, and proteomic data generated by high-throughput experimental technologies, and in organizing information gathered from traditional biology and medicine.
The Global Genomics market has been valued at USD 13.45 Billion in 2016 and is expected to grow at a CAGR of 10.2% to reach to USD 23.88 Billion by 2022. The growth of the overall market for genomic all the branches can be attributed to the growing demand for personalized medicine, growing investments, grants, and funds by the government; rise in research activities in the field of genomics; increasing number of start-up companies; and increasing application of genomic sequencing in the diagnostics. North America is expected to account for the largest share of the global Genomics market. Base year considered for the report is 2016 and the forecast period includes 2017–2022.
Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of Genomics market. Various secondary sources such as associations like the International Chromosome and Genome Society (ICGS), International Mammalian Genome Society, Center for Genomics and Society, Association of Environmental Mutagenesis and Genomics Societies (IAEMGS), National Human Genome Research Institute (NHGRI), the American Society of Human Genetics, Genetics Society of America (GSA), Genome Canada, European Society of Human Genetics (ESHG), British Society for Human Genetics, Genetic Society of China (GSC), the Genetic Society of Japan, Indian Society of Genetics, Biotechnology Research & Development, the Indian Society of Genetics and Plant Breeding (ISGPB), Human Genetics Society of Australasia, Brazilian Association of Mutagenesis have been used to identify and collect information useful for the study of the genomic market.
- Genomics research organizations and genomic researchers
- Genetics Associations and Societies
- Genetic Counselors
- Academic institutes
- Government and private research institutes
- Medical research centers
- Public and private health agencies
- Genomics and biotechnology associations
- Genomic Students
- Genomics Faculty
- Genomics Scientists
- Pharmacology Scientists and Health Professionals
- Bio pharmacists
- Business Entrepreneurs
- Training Institutes
- Software developing companies
- Data Management Companies